Literature DB >> 889337

Xanthoma disseminatum. Clinical, metabolic, pathologic, and radiologic aspects.

M A Mishkel, W P Cockshott, D J Nazir, D Rosenthal, W P Spaulding, A Wynn-Williams.   

Abstract

A 55-year-old man with the classical mucocutaneous lesions of xanthoma disseminatum has been followed up for a period of 13 years. The special features of this case, which make it unique, are as follows: (1) the availability of histologic data on multiple lesions for more than a ten-year period; (2) the progressive nature of the multiple osseous lesions; (3) the metabolic studies that show no evidence for accumulation of abnormal sterols in a xanthoma, the blood, or intestinal aspirate; (4) the development of hypothyroidism and symptoms or signs, or both, of an intracerebral and an intraspinal lesion; (5) the partial regression of the cutanous symptoms and lesions while receiving clofibrate, in spite of progression of the mucous membrane and osseous lesions, and (6) the failure to develop diabetes insipidus to date.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 889337     DOI: 10.1001/archderm.113.8.1094

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Xanthoma disseminatum.

Authors:  G P Ford; R D Eady; A J Freemont
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

2.  Xanthoma disseminatum: a rare intracranial mass.

Authors:  Neeraj B Chepuri; Venkat R Challa
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

3.  Xanthoma disseminatum in a pair of blind, deaf male twins.

Authors:  Naveed Natanzi; David Peng; Eli Ahdoot; Sandra Ghatan; Amy Reinstandler; Ramin Ram
Journal:  ISRN Dermatol       Date:  2011-03-15

Review 4.  Disseminated intracranial xanthoma disseminatum: a rare case report and review of literature.

Authors:  Guang-Zhi Yang; Jing Li; Lu-Ping Wang
Journal:  Diagn Pathol       Date:  2016-08-17       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.